NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells (2022)
- Authors:
- USP affiliated authors: TRAINA, FABÍOLA - FMRP ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: FMRP; ICB; FM
- DOI: 10.1038/s41598-022-21419-6
- Subjects: FARMACOLOGIA; NEOPLASIAS PULMONARES; ANTINEOPLÁSICOS; NEOPLASIAS PULMONARES; ANTINEOPLÁSICOS; CÉLULAS CULTIVADAS DE TUMOR; ONCOGENES; TRANSDUÇÃO DE SINAL CELULAR; PROTEÍNAS PROTO-ONCOGÊNICAS; PROTEÍNAS QUINASES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v. 12, art. 17092, p. 1-11, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MIRANDA, Lívia Bassani Lins De et al. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-21419-6. Acesso em: 02 dez. 2025. -
APA
Miranda, L. B. L. D., Lima, K., Silva, J. L. C., Traina, F., Kobayashi, S. S., & Machado Neto, J. A. (2022). NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, 12, 1-11. doi:10.1038/s41598-022-21419-6 -
NLM
Miranda LBLD, Lima K, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1038/s41598-022-21419-6 -
Vancouver
Miranda LBLD, Lima K, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1038/s41598-022-21419-6 - Investigation of the effects of NT157, a multitarget anticancer drug, in lung cancer cell models
- NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
- Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- DNMT3A is highly expressed in bone marrow cells from acute myeloid leukemia patients
- Stathmin 1 expression in plasma cell neoplasms. [Carta]
- IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. [Carta]
- Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation
- De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
- Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival
Informações sobre o DOI: 10.1038/s41598-022-21419-6 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
NT157 exerts antineoplast... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
